📰 John Alam News
John Alam News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Alam. Real-time updates on events, politics, business and more.
June 21, 2024
Give workers space. But the pay off comes later when a median barrier finally comes to the golden gate. Its always been one of the more unique and dangerous aspects of the bridge, oncoming cars whisk by with inches between them. No room for error. Plastic pylons soon to be replaced by a movable barrier. A foot across each section over 1,000 pounds. Production against a driver who drifts or is distracted. For people to look around. I think its a good idea. Reporter flexibility for commute. A tall...
May 20, 2024
BOSTON, May 20, 2024 -- CervoMed Inc. , a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced the appointment of William Elder as Chief...
March 9, 2024
Key Insights CervoMed's significant insider ownership suggests inherent interests in company's expansion The top 3...
February 20, 2024
CervoMed Inc CEO John Alam joined Steve Darling from Proactive to announce a significant addition to the companys leadership team.CervoMed has appointed Joshua Boger to its Board of Directors as...
February 7, 2024
Dr. Boger is the founder, and retired CEO and Board Chair, of Vertex Pharmaceuticals CervoMed on track to complete enrollment in 1H 2024 in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with
January 10, 2024
MIAMI, Jan. 10, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 66th Emerging...
October 25, 2023
/PRNewswire/ -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, announced an...
October 18, 2023
/PRNewswire/ -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced...
September 6, 2023
/PRNewswire/ -- CervoMed Inc., a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced the...
August 16, 2023
/PRNewswire/ -- CervoMed Inc. (formerly known as Diffusion Pharmaceuticals Inc.) (NASDAQ: CRVO), now a clinical-stage company focused on developing treatments...